Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reinhard Ruckser

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Wiener Medizinische Wochenschrift (1946)|November 8, 2022
[Colorectal cancer]Cheng Zhang, Margarete Stampfl-Mattersberger, Reinhard Ruckser, et al.
Cancers|October 23, 2021
Advances in the Treatment of Relapsed and Refractory Multiple Myeloma in Patients with Renal Insufficiency: Novel Agents, Immunotherapies and BeyondBoris Bozic, Jens Rutner, Chang Zheng, et al.
European Journal of Haematology|April 3, 2016
Influence of platelet and white blood cell counts on major thrombosis - analysis from a patient registry in essential thrombocythemiaVeronika Buxhofer-Ausch, Michael Steurer, Siegfried Sormann, et al.
Plos One|December 24, 2011
Changes in human fecal microbiota due to chemotherapy analyzed by TaqMan-PCR, 454 sequencing and PCR-DGGE fingerprintingJutta Zwielehner, Cornelia Lassl, Berit Hippe, et al.
European Journal of Haematology|September 10, 2020
Impact of platelets on major thrombosis in patients with a normal white blood cell count in essential thrombocythemiaVeronika Buxhofer-Ausch, Dominik Wolf, Siegfried Sormann, et al.
European Journal of Haematology|April 1, 2018
Impact of white blood cells on thrombotic risk in patients with optimized platelet count in essential thrombocythemiaVeronika Buxhofer-Ausch, Michael Steurer, Siegfried Sormann, et al.
International Journal of Clinical Pharmacology and Therapeutics|December 11, 2013
Vascular endothelia growth factor targeted therapy may improve the effect of dendritic cell-based cancer immune therapyJohanna Buchroithner, Josef Pichler, Christine Marosi, et al.
European Journal of Haematology|July 13, 2004
A rare case of interstitial pneumonitis after tandem high-dose melphalan conditioning and autologous stem cell transplantation in multiple myelomaVeronika Buxhofer-Ausch, Reinhard Ruckser, Peter Kier, et al.
Journal of Clinical Apheresis|September 1, 2016
Plerixafor as preemptive strategy results in high success rates in autologous stem cell mobilization failureNina Worel, Gerhard Fritsch, Hermine Agis, et al.
Cancers|October 11, 2018
Audencel Immunotherapy Based on Dendritic Cells Has No Effect on Overall and Progression-Free Survival in Newly Diagnosed Glioblastoma: A Phase II Randomized TrialJohanna Buchroithner, Friedrich Erhart, Josef Pichler, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Wiener Medizinische Wochenschrift (1946)|November 8, 2022
[Colorectal cancer]Cheng Zhang, Margarete Stampfl-Mattersberger, Reinhard Ruckser, et al.
Cancers|October 23, 2021
Advances in the Treatment of Relapsed and Refractory Multiple Myeloma in Patients with Renal Insufficiency: Novel Agents, Immunotherapies and BeyondBoris Bozic, Jens Rutner, Chang Zheng, et al.
European Journal of Haematology|April 3, 2016
Influence of platelet and white blood cell counts on major thrombosis - analysis from a patient registry in essential thrombocythemiaVeronika Buxhofer-Ausch, Michael Steurer, Siegfried Sormann, et al.
Plos One|December 24, 2011
Changes in human fecal microbiota due to chemotherapy analyzed by TaqMan-PCR, 454 sequencing and PCR-DGGE fingerprintingJutta Zwielehner, Cornelia Lassl, Berit Hippe, et al.
European Journal of Haematology|September 10, 2020
Impact of platelets on major thrombosis in patients with a normal white blood cell count in essential thrombocythemiaVeronika Buxhofer-Ausch, Dominik Wolf, Siegfried Sormann, et al.
European Journal of Haematology|April 1, 2018
Impact of white blood cells on thrombotic risk in patients with optimized platelet count in essential thrombocythemiaVeronika Buxhofer-Ausch, Michael Steurer, Siegfried Sormann, et al.
International Journal of Clinical Pharmacology and Therapeutics|December 11, 2013
Vascular endothelia growth factor targeted therapy may improve the effect of dendritic cell-based cancer immune therapyJohanna Buchroithner, Josef Pichler, Christine Marosi, et al.
European Journal of Haematology|July 13, 2004
A rare case of interstitial pneumonitis after tandem high-dose melphalan conditioning and autologous stem cell transplantation in multiple myelomaVeronika Buxhofer-Ausch, Reinhard Ruckser, Peter Kier, et al.
Journal of Clinical Apheresis|September 1, 2016
Plerixafor as preemptive strategy results in high success rates in autologous stem cell mobilization failureNina Worel, Gerhard Fritsch, Hermine Agis, et al.
Cancers|October 11, 2018
Audencel Immunotherapy Based on Dendritic Cells Has No Effect on Overall and Progression-Free Survival in Newly Diagnosed Glioblastoma: A Phase II Randomized TrialJohanna Buchroithner, Friedrich Erhart, Josef Pichler, et al.
Pageof 2